Skip to content
value.today

Elligint Health, Inc.

🇺🇸 Edison, New Jersey, USATechnologyFounded 2024
Total raised
$7 M
1 round on record
Latest round
$7 M
May 2026
First round on record
May 2026
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Elligint Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$7 MNo. 1$2 to $10 million

Elligint Health, Inc.: Raise no. 1, May 2026

Investors in this round

5 investors had bought by the notice of Nov 19, 2026: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Caramanico · Executive Officer, Director
  • Sumesh P. Poyil · Executive Officer
  • Adam Sabloff · Director
  • Ashish Kapoor · Director
  • Danielle Bellanger · Director
  • Enrico Picozza · Director
  • Gregg Michaelson · Director
  • Lenard Marcus · Director
  • Michael Ludwig · Director
  • Steven Tolle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering.”

Signed by Christopher J. Caramanico, President. Source: SEC Form D, newest notice filed Nov 19, 2026. Read the notice at the SEC.

equitySEC
Dec 2024$13 MIssued in a merger or acquisition$10 to $50 million

Elligint Health, Inc.: Private sale, Dec 2024

Investors in this round

56 investors had bought by the notice of Jun 27, 2025: 50 accredited, 6 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Caramanico · Executive Officer, Director
  • Sumesh P. Poyil · Executive Officer
  • Adam Sabloff · Director
  • Ashish Kapoor · Director
  • Danielle Bellanger · Director
  • Enrico Picozza · Director
  • Gregg Michaelson · Director
  • Lenard Marcus · Director
  • Michael Ludwig · Director
  • Steven Tolle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount sold includes contributions of capital to HealthEC, LLC in the aggregate amount of $2,800,000 immediately prior to the closing of the transactions under the Agreement and Plan of Merger and Contribution dated December 27, 2024.”
  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering.”
  • On a merger: “The offering is made in connection with the merger of a wholly owned subsidiary of the issuer into Virtual Frameworks, Inc. and the contribution of securities of HealthEC, LLC pursuant to an agreement dated December 27, 2024.”

Signed by Chris Caramanico, President. Source: SEC Form D and 2 amendments, newest notice filed Jun 27, 2025. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Elligint Health, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2026).

    SEC Form D · Nov 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Nov 2026

That is all the official record says: Elligint Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Elligint Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Elligint Health, Inc.
NameRoleNamed in
Chris CaramanicoExecutive officerNov 2026
Sumesh P. PoyilExecutive officerNov 2026
Adam SabloffDirectorNov 2026
Ashish KapoorDirectorNov 2026
Chris CaramanicoDirectorNov 2026
Danielle BellangerDirectorNov 2026
Enrico PicozzaDirectorNov 2026
Gregg MichaelsonDirectorNov 2026
Lenard MarcusDirectorNov 2026
Michael LudwigDirectorNov 2026
Steven TolleDirectorNov 2026